Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer von Borghaei, Hossein, Paz-Ares, Luis, Horn, Leora, Spigel, David R, Steins, Martin, Ready, Neal E, Chow, Laura Q, Vokes, Everett E, Felip, Enriqueta, Holgado, Esther, Barlesi, Fabrice, Kohlhäufl, Martin, Arrieta, Oscar, Burgio, Marco Angelo, Fayette, Jérôme, Lena, Hervé, Poddubskaya, Elena, Gerber, David E, Gettinger, Scott N, Rudin, Charles M, Rizvi, Naiyer, Crinò, Lucio, Blumenschein, George R, Antonia, Scott J, Dorange, Cécile, Harbison, Christopher T, Graf Finckenstein, Friedrich, Brahmer, Julie R

Volltext

PAX-FKHR function as pangenes by simultaneously inducing and inhibiting myogenesis von Graf Finckenstein, F, Shahbazian, V, Davicioni, E, Ren, Y-X, Anderson, M J

Volltext

MA15.08 Multicenter Phase II Trial of LN-145 TIL Cell Therapy plus Pembrolizumab in Patients with ICI-Naïve Metastatic NSCLC von Schoenfeld, A.J., He, K., Chesney, J., Garon, E., Nieva, J., Sacher, A., Lee, S., Graf Finckenstein, F., Fiaz, R., Catlett, M., Chen, G., Gontcharova, V., Creelan, B.C.

Volltext

883TiP A phase I/II open-label study (IOV-GM1-201) of TALEN-mediated PD-1 inactivated autologous tumor-infiltrating lymphocytes (TIL; IOV-4001) in patients with advanced melanoma a... von Chesney, J., Wise-Draper, T., Sarnaik, A.A., Graf Finckenstein, F., Hari, P., Jagasia, M., Desai, A., Suzuki, A., Wu, X., Betof Warner, A.

Volltext

1086MO Lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in patients (pts) with advanced mucosal melanoma after progression on immune checkpoint inhibitors (ICI): Results... von Grigoleit, G-U., Kluger, H., Thomas, S., Chesney, J.A., Domingo-Musibay, E., Sanmamed, M.F., Medina, T., Ziemer, M., Whitman, E., Graf Finckenstein, F., Chou, J., Wu, X., Sulur, G., Shi, W., Sarnaik, A.

Volltext

EP08.01-110 Trial in Progress: A Phase 2 Multicenter Study (IOV-LUN-202) of Autologous Tumor-infiltrating Lymphocyte (TIL) Cell Therapy (LN-145) in mNSCLC von Chesney, J.A., Schoenfeld, A.J., Wise-Draper, T., Sukari, A., He, K., Graf Finckenstein, F., Hari, P., Jagasia, M., Samakoglu, S., Leighton-Swayze, A., Chen, G., Hong, Y.K.

Volltext

188TiP A phase II multicenter study of autologous tumor infiltrating lymphocytes (TIL, LN-145) cell therapy in patients with metastatic non-small cell lung cancer (mNSCLC) von Massarelli, E., Goldberg, Z., Cacovean, A., Yadav, B., Chen, G., Jagasia, M., Finckenstein, F. Graf, Fardis, M., Sukari, A.

Volltext

844P Efficacy and safety of lifileucel, an investigational autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma previously treated with a... von Larkin, J., Dalle, S., Sanmamed, M.F., Wilson, M., Hassel, J.C., Kluger, H., Orloff, M., Weber, J.S., Graf Finckenstein, F., Hari, P., Jagasia, M., Yin, H., Shi, W., Sulur, G., Wu, X., Gontcharova, V., Lewis, K.

Volltext

P14.05 Phase 2, Study of Iovance Autologous Tumor Infiltrating Lymphocytes (Lifileucel, LN-144, LN-145, LN-145-S1) In Patients With Solid Tumors von Gettinger, S., Kluger, H., Schoenfeld, A., Warner, A. Betof, He, K., Sukari, A., Thomas, S., Doger, B., Lee, S., Haefliger, S., Goldberg, Z., Cacovean, A., Fiaz, R., Chen, G., Jagasia, M., Finckenstein, F. Graf, Fardis, M., Jimeno, A.

Volltext

P14.04 A Phase 2 Multicenter Study of Iovance Autologous Tumor Infiltrating Lymphocytes (TIL, LN-145) Cell Therapy in Patients With Metastatic NSCLC von Massarelli, E., Schoenfeld, A., Chesney, J., Hong, Y., Lammers, P., Nieva, J., Wise-Draper, T., Goldberg, Z., Cacovean, A., Yadav, B., Chen, G., Jagasia, M., Finckenstein, F. Graf, Fardis, M., Sukari, A.

Volltext

187TiP Phase II, multicenter study of autologous tumor infiltrating lymphocytes (TIL, LN 144/LN-145/LN-145-S1) in patients with solid tumours von Gettinger, S., Kluger, H., Schoenfeld, A., Warner, A. Betof, He, K., Sukari, A., Thomas, S.S., de Spéville, B. Doger, Lee, S., Haefliger, S., Goldberg, Z., Cacovean, A., Fiaz, R., Chen, G., Jagasia, M., Finckenstein, F. Graf, Fardis, M., Jimeno, A.

Volltext

119O Long-term efficacy and patterns of response of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in patients with advanced melanoma: A 4-year analysis of the C-144-0... von Medina, T., Chesney, J.A., Whitman, E., Kluger, H., Thomas, S., Sarnaik, A., Kirkwood, J.M., Larkin, J., Weber, J.S., Hamid, O., Wermke, M., Finckenstein, F. Graf, Chou, J., Gastman, B., Sulur, G., Wu, X., Shi, W., Domingo-Musibay, E.

Volltext

Effect of IGF-1R inhibitor BMS-754807 on tumor glucose metabolism and proliferation in Sal-IGF xenografts by FDG and FLT- PET imaging von Chow, P. L., Ho, C. P., Kan, D., Attar, R. M., Graf Finckenstein, F., Carboni, J. M., Galbraith, S. M., Lee, F. Y., Gottardis, M. M., Krishnan, B. S.

Volltext

Hämatopoetische Stammzelltransplantation vom Fremdspender bei Kindern: Niedrige Toxizität durch GvHD-Prophylaxe mit CSA, MTX, Metronidazol, iv-Immunglobulin und ATG von Graf Finckenstein, F., Zabelina, T., Dürken, M., Dahlke, J., Kröger, N., Krüger, W., Janka-Schaub, G., Erttmann, R., Zander, A. R., Kabisch, H.

Volltext

412 BMS-754807, an oral dual IGF-1R/insulin receptor (IR) inhibitor: initial results from a Phase 1 dose- and schedule-finding study in combination with carboplatin/paclitaxel in s... von Chu, Q.S, Kim, S.W, Ellis, P.M, Mileshkin, L, de Boer, R.H, Park, J.S, Pellas, T, Huang, F, Finckenstein, F. Graf, Dhar, A

Volltext

Unrelated donor stem cell transplantation in children: low toxicity using a GvHD-prophylaxis regimen with CSA, MTX, metronidazole,iv-immunoglobulin and ATG von Graf Finckenstein, F, Zabelina, T, Dürken, M, Dahlke, J, Kröger, N, Krüger, W, Janka-Schaub, G, Erttmann, R, Zander, A R, Kabisch, H

Volltext

Hämatopoetische Stammzelltransplantation vom Fremdspender bei Kindern: Niedrige Toxizität durch GvHD-Prophylaxe mit CSA, MTX, Metronidazol, iv-Immunglobulin und ATG von Graf Finckenstein, F., Zabelina, T., Dürken, M., Dahlke, J., Kröger, N., Krüger, W., Janka-Schaub, G., Erttmann, R., Zander, A. R., Kabisch, H.

Volltext

Untersuchung des N-myc Status beim Neuroblastom aus Knochenmarkzellen von Brack, T., Finckenstein, F. Graf, Kabisch, H.

Volltext

Untersuchung des N-myc Status beim Neuroblastom aus Knochenmarkzellen von BRACK, T, FINCKENSTEIN, F. G, KABISCH, H

Volltext

Dual IGF-1R/InsR Inhibitor BMS-754807 Synergizes with Hormonal Agents in Treatment of Estrogen-Dependent Breast Cancer von XIAONAN HOU, FEI HUANG, HALUSKA, Paul, MACEDO, Luciana F, HARRINGTON, Sean C, REEVES, Karen A, GREER, Ann, GRAF FINCKENSTEIN, Friedrich, BRODIE, Angela, GOTTARDIS, Marco M, CARBONI, Joan M

Volltext